I
n a rapidly changing life sciences landscape, ABI-LAB stands out as a reliable partner for early-stage and expanding companies. The company's state-of-the-art lab spaces are designed to accelerate growth, making it an attractive option in today's volatile market.

    Gary Kaufman, Co-Founder and COO of ABI-LAB, shared insights on the company's unique niche and critical services offered to life sciences startups and growing enterprises in a recent Face-to-Face interview with Boston Real Estate Times. Kaufman will also be a featured speaker at the upcoming Boston Life Sciences Conference on April 17, 2025.

    As co-founder and COO of ABI-LAB, Kaufman has played a key role in fostering biotech innovation. With over 30 years of entrepreneurial experience, he brings a diverse background to the company. In addition to his work at ABI-LAB, Kaufman serves as president of Shelby Enterprises Inc. and is involved with various other organizations promoting life sciences growth.

    ABI-LAB's commitment to supporting life sciences companies is evident in its dedication to providing scalable, flexible lab spaces for early-stage development. The company recently celebrated the opening of its third facility, expanding its total footprint to 112,000 square feet. These cutting-edge facilities feature advanced instrumentation and equipment suitable for BL1 and BL2 applications.

    ABI-LAB's focus on removing operational and financial barriers enables life sciences companies to concentrate on innovation. By supporting the growth of biotech, pharma, and medical companies, ABI-LAB is driving breakthroughs in the life sciences industry.